Stay updated with breaking news from Trinity Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research note released on Tuesday. The firm issued a buy rating on the stock. Trinity Biotech Trading Up 5.1 % Shares of TRIB stock opened at $0.41 on Tuesday. Trinity Biotech has a 1-year low of $0.37 and a 1-year high […]
DUBLIN, Ireland, Dec. 27, 2023 -- Trinity Biotech plc , a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announces it has...
John Gillard Named Chief Executive OfficerDes Fitzgerald Named Interim Chief Financial OfficerDUBLIN, Ireland, Dec. 18, 2023 (GLOBE NEWSWIRE) --...
As per the report by Fortune Business Insights, the Infectious Disease Point-of-care (POC) Diagnostics Market size is projected to reach USD 12.46 billion...